• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现β-arrestin 偏向性 25CN-NBOH 衍生 5-HT 受体激动剂。

Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT Receptor Agonists.

机构信息

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK─2100 Copenhagen, Denmark.

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Campus Heymans, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.

出版信息

J Med Chem. 2022 Sep 22;65(18):12031-12043. doi: 10.1021/acs.jmedchem.2c00702. Epub 2022 Sep 13.

DOI:10.1021/acs.jmedchem.2c00702
PMID:36099411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9511481/
Abstract

The serotonin 2A receptor (5-HTR) is the mediator of the psychedelic effects of serotonergic psychedelics, which have shown promising results in clinical studies for several neuropsychiatric indications. The 5-HTR is able to signal through the Gα and β-arrestin effector proteins, but it is currently not known how the different signaling pathways contribute to the therapeutic effects mediated by serotonergic psychedelics. In the present work, we have evaluated the subtype-selective 5-HTR agonist 25CN-NBOH and a series of close analogues for biased signaling at this receptor. These ligands were designed to evaluate the role of interactions with Ser159. The lack of interaction between this hydroxyl moiety and Ser159 resulted in detrimental effects on potency and efficacy in both βarr2 and miniGα recruitment assays. Remarkably, Gα-mediated signaling was considerably more affected. This led to the development of the first efficacious βarr2-biased 5-HTR agonists and , βarr2 preferring, relative to lysergic acid diethylamide (LSD).

摘要

5-羟色胺 2A 受体(5-HTR)是血清素能致幻剂致幻作用的介质,这些致幻剂在几种神经精神疾病的临床研究中显示出了有希望的结果。5-HTR 能够通过 Gα 和β-arrestin 效应蛋白进行信号传递,但目前尚不清楚不同的信号通路如何为血清素能致幻剂介导的治疗效果做出贡献。在本工作中,我们评估了 5-HTR 亚型选择性激动剂 25CN-NBOH 及其一系列密切类似物在该受体上的偏置信号转导。这些配体旨在评估与 Ser159 相互作用的作用。缺乏该羟基与 Ser159 之间的相互作用导致在βarr2 和 miniGα招募测定中效力和功效都受到不利影响。值得注意的是,Gα 介导的信号转导受到的影响更大。这导致了第一个有效的βarr2 偏向性 5-HTR 激动剂的开发 和 ,与麦角酸二乙酰胺(LSD)相比,βarr2 更倾向于它们。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/9f7cbb02ebb5/jm2c00702_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/0afa03e372ef/jm2c00702_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/06a5c75bb7cb/jm2c00702_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/728e7d878431/jm2c00702_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/41250762063f/jm2c00702_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/b910ddefbde2/jm2c00702_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/4acdceb06cce/jm2c00702_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/9f7cbb02ebb5/jm2c00702_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/0afa03e372ef/jm2c00702_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/06a5c75bb7cb/jm2c00702_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/728e7d878431/jm2c00702_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/41250762063f/jm2c00702_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/b910ddefbde2/jm2c00702_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/4acdceb06cce/jm2c00702_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e93/9511481/9f7cbb02ebb5/jm2c00702_0007.jpg

相似文献

1
Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT Receptor Agonists.发现β-arrestin 偏向性 25CN-NBOH 衍生 5-HT 受体激动剂。
J Med Chem. 2022 Sep 22;65(18):12031-12043. doi: 10.1021/acs.jmedchem.2c00702. Epub 2022 Sep 13.
2
The selective 5-HT receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [H]25CN-NBOH.选择性 5-HT 受体激动剂 25CN-NBOH:[H]25CN-NBOH 的结构-活性关系、体内药理学以及体外和离体结合特性。
Biochem Pharmacol. 2020 Jul;177:113979. doi: 10.1016/j.bcp.2020.113979. Epub 2020 Apr 13.
3
Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HTR through simultaneous use of β-arrestin 2 and miniGα bioassays.通过同时使用β-抑制蛋白2和miniGα生物测定法鉴定对5-羟色胺受体表现出偏向性激动作用的致幻新型精神活性物质(NPS)。
Biochem Pharmacol. 2020 Dec;182:114251. doi: 10.1016/j.bcp.2020.114251. Epub 2020 Sep 28.
4
Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT Receptor Agonists in Mice.迷幻和非迷幻 5-HT 受体激动剂在小鼠中的耐受性和交叉耐受性。
ACS Chem Neurosci. 2022 Aug 17;13(16):2436-2448. doi: 10.1021/acschemneuro.2c00170. Epub 2022 Jul 28.
5
Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT Receptor Agonists.一组苯乙胺 5-HT 受体激动剂的偏向激动作用的结构-活性评估和深入分析。
ACS Chem Neurosci. 2023 Aug 2;14(15):2727-2742. doi: 10.1021/acschemneuro.3c00267. Epub 2023 Jul 20.
6
Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.致幻 5-HT2AR 激动剂 LSD 和 DOI 增强多巴胺 D2R 原聚体识别和 D2-5-HT2A 异源受体复合物的信号转导。
Biochem Biophys Res Commun. 2014 Jan 3;443(1):278-84. doi: 10.1016/j.bbrc.2013.11.104. Epub 2013 Dec 2.
7
Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.慢性给予代谢型谷氨酸 2/3 受体激动剂可减弱对苯乙胺类致幻剂的行为反应。
Psychopharmacology (Berl). 2019 Feb;236(2):821-830. doi: 10.1007/s00213-018-5118-y. Epub 2018 Nov 17.
8
Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of -(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT Receptor Agonist.-(2-羟基苄基)-2,5-二甲氧基-4-氰基苯乙胺(25CN-NBOH)的体外药理学和药代动力学特性的详细表征,一种高选择性且可穿透血脑屏障的5-羟色胺受体激动剂
J Pharmacol Exp Ther. 2017 Jun;361(3):441-453. doi: 10.1124/jpet.117.239905. Epub 2017 Mar 30.
9
The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice.选择性 5-HT2A 受体激动剂 25CN-NBOH 不影响小鼠的反转学习。
Behav Pharmacol. 2021 Aug 1;32(5):448-452. doi: 10.1097/FBP.0000000000000626.
10
25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.25CN-NBOH:一种用于血清素 2A 受体的体外和体内研究的选择性激动剂。
ChemMedChem. 2021 Nov 5;16(21):3263-3270. doi: 10.1002/cmdc.202100395. Epub 2021 Aug 21.

引用本文的文献

1
Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2AR) modulators.血清素2A受体(5-HT2AR)调节剂差异效应的分子动力学研究
PLoS Comput Biol. 2025 Sep 3;21(9):e1013000. doi: 10.1371/journal.pcbi.1013000. eCollection 2025 Sep.
2
Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.裸盖菇素作为快速起效的变革性抗抑郁药:药理特性与分子机制
Fundam Clin Pharmacol. 2025 Aug;39(4):e70038. doi: 10.1111/fcp.70038.
3
Design, Synthesis, and In Vitro Characterization of a Tryptamine-Based Visible-Light Photoswitchable 5-HTR Ligand Showing Efficacy Preference for β-Arrestin over Mini-Gq.

本文引用的文献

1
Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT Receptor Agonists.一组苯乙胺 5-HT 受体激动剂的偏向激动作用的结构-活性评估和深入分析。
ACS Chem Neurosci. 2023 Aug 2;14(15):2727-2742. doi: 10.1021/acschemneuro.3c00267. Epub 2023 Jul 20.
2
Structure-based discovery of nonhallucinogenic psychedelic analogs.基于结构的非致幻迷幻剂类似物的发现。
Science. 2022 Jan 28;375(6579):403-411. doi: 10.1126/science.abl8615. Epub 2022 Jan 27.
3
In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT R.
基于色胺的可见光光开关5-羟色胺受体配体的设计、合成及体外表征:对β-抑制蛋白而非小Gq蛋白显示出功效偏好
J Med Chem. 2025 Jul 10;68(13):13628-13639. doi: 10.1021/acs.jmedchem.5c00442. Epub 2025 Jun 18.
4
5-HT receptors: Pharmacology and functional selectivity.5-羟色胺受体:药理学与功能选择性
Pharmacol Rev. 2025 Jul;77(4):100059. doi: 10.1016/j.pharmr.2025.100059. Epub 2025 Apr 23.
5
Minute-timescale free-energy calculations reveal a pseudo-active state in the adenosine A receptor activation mechanism.分钟时间尺度的自由能计算揭示了腺苷A受体激活机制中的一种假活性状态。
Chem. 2024 Dec 12;10(12):3678-3698. doi: 10.1016/j.chempr.2024.08.004.
6
Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties.5-甲氧基-DMT 衍生物的血清素能结构-活性关系:对精神活性和体温调节特性的深入了解。
Mol Psychiatry. 2024 Aug;29(8):2346-2358. doi: 10.1038/s41380-024-02506-8. Epub 2024 Mar 14.
7
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited.重新审视利苏瑞ide与麦角酸二乙酰胺的比较药理作用。
ACS Pharmacol Transl Sci. 2024 Feb 5;7(3):641-653. doi: 10.1021/acsptsci.3c00192. eCollection 2024 Mar 8.
8
Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures.基于分子结构探索靶向 G 蛋白偶联受体和关键膜受体的新型抗抑郁药。
Molecules. 2024 Feb 22;29(5):964. doi: 10.3390/molecules29050964.
9
Psychedelic-like Activity of Norpsilocin Analogues.具有迷幻样活性的诺匹克隆类似物。
ACS Chem Neurosci. 2024 Jan 17;15(2):315-327. doi: 10.1021/acschemneuro.3c00610. Epub 2024 Jan 8.
10
Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT Receptor Agonists.一组苯乙胺 5-HT 受体激动剂的偏向激动作用的结构-活性评估和深入分析。
ACS Chem Neurosci. 2023 Aug 2;14(15):2727-2742. doi: 10.1021/acschemneuro.3c00267. Epub 2023 Jul 20.
在体外测定(迷幻)物质在血清素受体 5-HT R 上的功能特征。
J Neurochem. 2022 Jul;162(1):39-59. doi: 10.1111/jnc.15570. Epub 2022 Jan 17.
4
25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.25CN-NBOH:一种用于血清素 2A 受体的体外和体内研究的选择性激动剂。
ChemMedChem. 2021 Nov 5;16(21):3263-3270. doi: 10.1002/cmdc.202100395. Epub 2021 Aug 21.
5
The Alkaloids from and Other "False Peyotes".来自[具体植物名称]及其他“假仙人球毒碱”植物的生物碱。 (你提供的原文中“from”后面缺少具体植物名称,这里补充了[具体植物名称]以便译文更通顺)
J Nat Prod. 2021 Aug 27;84(8):2398-2407. doi: 10.1021/acs.jnatprod.1c00381. Epub 2021 Jul 15.
6
OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space.OPLS4:改善化学空间挑战性领域的力场准确性。
J Chem Theory Comput. 2021 Jul 13;17(7):4291-4300. doi: 10.1021/acs.jctc.1c00302. Epub 2021 Jun 7.
7
Serotonin 2A Receptor (5-HTR) Activation by 25H-NBOMe Positional Isomers: Functional Evaluation and Molecular Docking.25H-NBOMe 位置异构体对血清素 2A 受体(5-HTR)的激活作用:功能评估与分子对接
ACS Pharmacol Transl Sci. 2021 Feb 25;4(2):479-487. doi: 10.1021/acsptsci.0c00189. eCollection 2021 Apr 9.
8
Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HTR through simultaneous use of β-arrestin 2 and miniGα bioassays.通过同时使用β-抑制蛋白2和miniGα生物测定法鉴定对5-羟色胺受体表现出偏向性激动作用的致幻新型精神活性物质(NPS)。
Biochem Pharmacol. 2020 Dec;182:114251. doi: 10.1016/j.bcp.2020.114251. Epub 2020 Sep 28.
9
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT Serotonin Receptor.致幻剂激活的 Gq 偶联 5-羟色胺受体的结构。
Cell. 2020 Sep 17;182(6):1574-1588.e19. doi: 10.1016/j.cell.2020.08.024.
10
In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.通过β-arrestin 2 募集到血清素 2A 受体来测定 30 种致幻新型精神活性物质的体外结构-活性关系。
Arch Toxicol. 2020 Oct;94(10):3449-3460. doi: 10.1007/s00204-020-02836-w. Epub 2020 Jul 5.